In the United States and Europe, the number of women with AIDS is increasing rapidly, both in absolute terms and as a ratio to menu. Thus in the US, 55% of all AIDS cases in women in the epidemic's first decade have occurred within the last two years'', Although injection drug use was the predominant mode of transmission initially, h~tero sexual transmission is becoming the dominant route", with all the potential this involves for much wider dissemination. In a Paris study, 20% of infections in women were attributed to heterosexual intercourse in 1987 4 . In 1989 the proportion was 58% and increasing.
In Africa, the scale of the problem and the potentially devastating consequences of maternal and childhood infection with HIV have long been recognized'', New worries surround reported increases in prevalence in South America", Thailand? and India".
In addition to the particularly harrowing problem of children becoming ill and losing parents, there are many unresolved scientific questions concerning mode, timing and prevention of vertical transmission. All these features combine to project pregnancy to the forefront of current concern in HIV infection.
In this necessarily limited review I will leave aside important issues such as testing and screening for HIV in pregnancy9-n and clinical managementlclt. Instead, I will restrict discussion to three areas which are contentious, but of intense research and clinical interest; the effect pregnancy has on HIV disease progression; the effect HIV has on pregnancy outcome; and vertical transmission.
Pregnancy and susceptibility to infectious disease
The evidence for a decline in immune response in pregnancy is conflicting. There is agreemen~that antibody mediated immunity is unchanged, WIthno alteration in B cell numberl", satisfactory antibody responses to vaccines in pregnancyI6-I8 and unchanged or slightly increased compl~me~t levels 19,20. Most studies have found a reduction in absolute T cell counts 15,21-23 but this could simply be a haemodilution effect, and there are differing reports about a decrease in CD 4 cells expressed as a percentage of total lymphocytes or as a CD 4/CD8 ratio 22 ,23. T lymphocyte function does not appear to be reduced 23,24. Current opinion suggests that systemic T cell function is maintain~d, bu~that th~re is some depression of cell mediated immumty, perhaps due to the raised levels of some steroid hormones and/or plasma proteins in pregnancy->. There are many studies which suggest increased virulence of a number of infectious diseases in pregnancy and these have been excellently reviewed 26.27. The methodology of many of these studies has been criticized-" but the totality of supporting evidence is impres~h.:e: Perh~ps th~be~t example of increased suscept~billty to Infec~lOn IS falciparum malaria-? but there IS also good evidence of increased risk with hepatitis 30,31, poli0 32-34 , influenza 35 • 36 and general clinical recognition of worsening of vulval papillomata'".
Progression of HIV disease
For the above reasons there have been persistent concerns that pregnancy may adversely affect progression of HIV disease. Initial reports tended to confirm these concems 37.38 • However, these studies were based on identification of mothers of children who had already developed AIDS, and who were themselves at particularly high risk".
Although several studies of the effect of pregnancy on the natural history of HIV disease are in progress, none have been reported in full. Two reports, one from Prances', the other from Haiti-', suggested higher progression to CDC IV disease in women who had completed a pregnancy compared to a nonpregnant control group. However, numbers were small, and whether the groups were comparable in time since seroconversion is not known. Similar studies from New York 42 The type of analysis used in all the above studies has implicit methodological problems of ensuring comparability of disease status between groups. Indeed, systematic bias could occur if iller women deliberately avoided pregnancy; if non-pregnant drug users were more likely to continue to injecr'": or if the non-pregnant group were significantly older. Another, and perhaps preferable, method is to study the effect pregnancy has on each woman's slope of fall in CD 4 lymphocyte count with time. She will thus be her own control, in terms of CD 4 decline before and after pregnancy. An attempt to do this was made by Biggar et aI. 48 . The authors believed their data were compatible with the hypothesis that pregnancy may mildly accelerate HIV induced depletion of CD 4 lymphocytes, and could therefore increase the rate of progression. However, they had no non-pregnant HIV seropositive control group, and this conclusion does not seem justified.
In short, conclusive evidence about the effect of pregnancy on longer term progression of HIV disease is lacking. Available studies have small numbers, relatively short follow up, and methodological problems. However, it seems unlikely that pregnancy has any major adverse effect on asymptomatic women.
AIDS in pregnancy
There are other possible ways in which pregnancy could affect disease. In susceptible, immunocompromised women, the additional pregnancyinduced fall could reduce CD 4 lymphocyte count below the threshold for opportunistic disease. Pregnancy could also increase the probability of an AIDS defining illness being fatal, or affect longer term prognosis after a CDC 4CI defining event.
Published case reports suggest that the outcome of AIDS in pregnancy is poor. In the United States, the first 6 reported cases of Pneumocystis carinii pneumonia (PCP) were fata1 49 -51 as was a case of listeria bacteraemia where AIDS was assumed'S. Further reports of pregnancy-associated deaths from AIDS have followed 53-55 • In contrast to this, as late as 1990, Hicks et a1. 56 described a single case of a woman who developed PCP during pregnancy but survived this initial episode. The authors claimed this was the first reported case of survival from PCP in pregnancy.
This bias to mortality is strikingly different from the situation in non-pregnant women. However, the gloomy outlook may simply represent reporting bias. Thus survival from PCP in pregnancy has been reported by others'". Physicians are more likely to report fatal cases, and perhaps journal editors are more likely to publish such reports. Nothing is known of non-fatal AIDS defining illness in the population from which these women are drawn, and there is no satisfactory information about survival time after AIDS in pregnancy.
The only series which addresses these issues, and has the advantage of being based on a total geographical population, is from Edinburgh'". Numbers are too small to provide reliable data, with only 22 women with AIDS, four of whom were pregnant. However, all three women who had PCP for the first time in pregnancy survived this initial episode, and survival time was not obviously reduced by the conjunction of AIDS and pregnancy.
Whether the onset of AIDS in pregnancy does carry a worse prognosis is not known. Because it remains an uncommon event in the developed world, and because the issue has not been specifically studied in Africa, it will be some time before this becomes clear.
EFFECT OF HIV INFECTION ON PREGNANCY OUTCOME
There are several theoretical ways in which HIV infection might affect pregnancy outcome'", Abortion Several studies have found an association between HIV seropositivity and a history of spontaneous abortion6<J-62 but these studies have the problem that the woman's HIV status during that pregnancy was unknown. A case control study in Nairobi showed HIV infection to be more common in women admitted with a spontaneous abortion, but the difference with control women whose pregnancy was continuing was not statistically significants". A small prospective study64 did not show an increase in spontaneous abortion. It is, therefore, uncertain at present whether HIV is directly associated.
Several studies have shown a higher HIV seroprevalence in women having induced abortion than in those continuing pregnancy65,66 and it might be expected that women infected with HIV would accept termination of pregnancz readily. Thus, 80% of pregnant women in France 7 and 83% of young women in New York 68 were in favour of abortion for HIV infected women. Women actually infected, behave differently however.
Studies from New Yorks? and Edinburgh/? have not shown termination of pregnancy to be chosen more commonly by HIV seropositive women compared to HIV seronegative drug using controls. Eighty-five per cent of women who tested HIV seropositive were estimated in a survey of major obstetric clinical centres to continue their pregnancy'".
Some of the reasons which underlie decision making about pregnancy were discussed by Selwyn'". However, local perception of illness and death due to HIV may influence choice, and in Edinburgh, seropositive women now seek termination of pregnancy significantly more often than controls.
Powerful factors motivate an asymptomatic infected woman to continue pregnancy, and counselling must be sensitive to the extremely difficult issues considered by her in making her decision.
Pregnancy complications
Early studies reported a high incidence of pre-term labour, caesarean section, syphylis and low birth weight7 2. 73. These studies were uncontrolled and illicit drug use and poverty are known to be associated with both HIV infection and poor pregnancy outcome.
The first controlled study, in Edinburgh women, most of whom had a history of drug use, showed both case and control groups to have a high incidence of pre-term labour, intrauterine growth retardation, and low birth weight. However, there were no differences according to HIV status?".
A prospective study of methadone clinic attenders in New York'" did not show differences in pregnancy complications and outcome, and nor did a larger study from New York'". Similar findings were reported from Milan/" and Toulouse?", These data from the United States and Europe contrast with much information from Africa. Several large studies from Zaire 78,79, Congo'", Zambia'", Kenya 82, Uganda's and Rwanda 84,85 compared pregnancy outcome in women who were, and were not, infected with HIV. These studies include 1832 infected mothers and 3911 HIV seronegative controls. HIV seropositivity was associated with; pre-term delivery in some studies 78-83 but not others 79,82,84,85; increased perinatal deaths in some studies 78,83,85 but no difference in others 82,84. An increase in chorioamnionitis in HIV positive pregnancies was report~d in one study78,. bl~edi~g in the third trimester m another'S, twmnmg m anotherBO. One large case control study from Kenya focused on stillbirth and low birth weight86. Linear logistic regression retained HIV status as a significant association of these adverse outcomes with odds ratios ranging from 2.0 to 2.9.
Although these reports on pregnancy complications are somewhat inconsistent, all of the African studies agree that birth weight is reduced in HIV infected women. The difference from controls ranges from 130 g84 to 232 g (calculated from ref 78) .
There is evidence that decrease in fetal size at birth is related to stage of maternal disease?". However, 
Reasons for the discrepancies between studies
The differences between African studies and those from Europe and the United States may arise partly from problems of methodology. Control groups in the African studies are loosely matched and clearly differ in other respects apart from HIV status. The differences tend to be in a direction which would favour the control groups as far as pregnancy outcome is concerned. Attempts have been made to allow for these differences using linear logistic regression, but residual distinguishing features may remain to confound the analysis.
There are other possible reasons for the discrepancies. The number of pregnancies studied in Europe and the United States is very small in comparison with the African studies and thus real differences could be missed. In addition, the great majority of women have been asymptomatic. In contrast 18% of women had AIDS in one African study" while 53% and 17% were symptomatic in others 81,82. Finally, the difference in African populations may be due to differential load of other infectious diseases (particularly malaria) and to differences in nutritional status. Basic data on malarial parasites and maternal weight do not seem to have been reported.
Conclusions
In asymptomatic women, HIV infect~on .per. se may be associated with a modest reduction m birth weight, but the effect on pregnancy appears to be slight. Under African conditions, t~ere may be increased rates of spontaneous abortIon,_ pre-term labour and stillbirth. When a woman bec~mes clinically ill, it seems inevitable that there will~e a detrimental effect on pregnancy, and there IS evidence that this is so.
TRANSMISSION OF INFECTION TO THE BABY
Infection could be transmitted to the baby in utero, at delivery, or by breast feeding. The relative importance of these routes is still not certain, although unlike other retroviruses breast feeding does not seem to be the major mode of spread. The outlook for infected children seems poor with one third becoming ill with HIV disease within the first year of life 89. There may be a bimodal pattern of disease in perinatally-acquired infection?'. . . Several early studies suggested that transmission of HIV could occur in utero S4 ,98,99 . Subsequently, successful culture of HIV-l was reported from 4 out of 14 second trimester fetuses 1OO,101 and HIV DNA sequence could be detected using polymerase chain reaction in 12 of 41 fetuses101-104. In all these studies, precautions were taken t~~inimize .t~e possibility of maternal cell contamination, but It IS difficult to exclude this beyond all doubt. One study which seems to have done this used a polymorphic DNA sequence adjacent to the cystic fibrosis locus 10S. These authors examined only fetuses where the mother was heterozygous, and the fetus homozygous, for this sequence. In 9 such fetuses, the maternal specific allele could not ?e~etected, thus excluding maternal cell contamination, but HIV-l DNA sequences were detected in 8.. Th.is seems a surprisingly high rate of HIV,d~tectIon In the light of known figures for transrrussion to~he child, and raises the possibility that defective fragments of DNA are being identified rather than true infection.
Timing and mode of transmission
Even though infection can be transmitted. e~rly in intrauterine life, it is not clear whether this IS the common or usual timing. The very early onset of clinical and immunological features in some infected children is suggestive. However, t~e fetus,could be infected late in pregnancy, during delivery by exposure to maternal blood or cervical ?,u~0l;ls,~r postnatally through breast fe~d~ng.~hIS .tImmg IS of critical importance because if infection IS usually around delivery, the risk might be reduced by prophylaxis (for example with large amounts of soluble CD 4 or zidovudine). Unfortun,at~ly, thouph this is such a key issue, many uncertainties remain.
The risk of vertical transmission
Early reports suggested a transmissi~n rat~of at least 50% but were biased by the inclusion of children who presented ill. Prospective studies have suggested rates of 13_39%78,81,87-89,106. The larg~st study reported is the European Collaborative Study89, Of 419 children born 18 months or more before analysis, 372 were of known infection status, 48 were infected (12.9%). A further 4 had repeatedly positive viral cultures, even though they had cleared maternal antibody. Some of the differences in these studies can be attributed to methodological problems, as was discussed in the paper from the European Collaborative Study'". Thus some studies included younger children who were ill, hence inflating the numerator artificially. Others had a low follow-up rate and one used virus culture on cord blood as an~nd point for infection.. N.eve~theless,~t s.ee~s likely that much of the variation m, trans.mIssion IS genuine and is related to population d~ferences. These include particularly stage of HIV disease, .but may also include other infections, and breast feedmg.
Factors influencing vertical transmission
These are becoming clearer. There are maternal features, probably mainly reflecting high viral load. Placental abnormality and fetal genotype may also be relevant.
There are accumulating, and convincing, data that transmission is particularly likely late in the course of disease'[? when the woman is severely immunocompromis~d. A French study108 rep?rted that 66% of 15 women with CD 4 count In pregnancy < 150/cm 3 , 50% of 24 women with P24 antigenaemia, and 78% of 14 women who displayed a high viral replication rate of HIV in culture, transmitted infection to their babies. The significance of a low maternal CD 4 lymphocyte count was confirmed by others 39,109 while a Nairobi study110 claimed that transmission correlated with maternal viral load as assessed by quantitative polymerase chain reaction.
In addition to late disease being a risk factor, there is evidence that vertical transmission is also likely in the first year after seroconversion-". This presumably also represents a time of higher viral load, before relative protection from broadly neutralizing antibody.
There is a search for more specific markers to identify those individuals most likely to transmit infection. This would help in counselling about pregnancy and ter~~ationa~d al~o co~d s~lect~:)llt pregnancies at sufficiently high nsk to justify tnals of drug prophylaxis. The .levels of antibody. to epitopes on the hypervanable V3 loop of VIral gp 120, or the MN primary neutralizing domain, have been found by some workers to be predictive of fetal infection106,111. This has not been confirmed by others 112 -117 and certainly infection does seem to have occurred despite hirh maternal levels of antibodies. Nsvami et ai. 11 may be correct when they suggest that any protective effect of antibod.i~s against gp 120 neutraliz~~g epitopes is type specific rather than group specific.
. As well as maternal factors, there are suggestions that placental damage may .be. associated, with an increased rate of transmission. There is an association with chorioamnionitis/s. The finding ?f a high transmission rate with mater~al anaerrua (though it could simply be a reflectIo~of~IV disease activity) could result from1Iralana,~~Ich preferentially infects the placenta . In addition, fetal genotype may be imp0I!ant.~ne study reported that susceptibility to HIV infection was related to genetic variation in HLA immune response genes'P, Finally, what obstetric factors could influence transmission? Invasive fetal procedures, (cordocentesis, scalp sampling, application of scalp electrodes etc) could result in micro-inoculation of the fetus with maternal blood and hence cause infection. Interestingly, the only fetal sample with maternal blood contamination in one study was the one where earlier cordocentesis had been performed'?'. Such procedures should therefore be avoided where the mother is infected. The role of caesarean section is unclear. In theory elective caesarean section could be protective by minimizing time spent by the baby exposed to cervical mucus and blood from cervical dilatation. A study of twins discordant for HIV transmission could give support to this 120. Of 15 discordant twin sets the first twin was infected in 13 cases, the second in only 2 (P=O.Ol). Infection of the baby has certainly occurred despite caesarean section being performed72,87.88.106.12:1. However, most studies do not clearly distinguish between elective caesarean section, with intact membranes, and caesarean section done after many hours in labour with ruptured membranes, where it would not be expected to be protective.
At present caesarean section should be performed for standard obstetric reasons only, but this advice may have to be revised as more evidence accumulates.
The situation with zidovudine is unclear. In the few cases reported so far, there have not been major problems with use during pregnancy122.123. However, infection of the infant has been documented despite zidovudine treatment throughout pregnancy124,125.
Breast feeding
Other retroviruses, such as Moloney murine leukaemia virus 126 or HTLV I in the human--? are spread principally by breast feeding. HIV-1 occurs in breast milk 128 and there is no doubt that infection has been transmitted to the baby postnatally by women infected by blood transfused for post partum haemorrhage129-131. In addition, an African study showed that 53% of women who were seronegative at birth but who later seroconverted, infected their babies-". In these situations, before the development of neutralizing antibody, viral load may be very high, and this may not parallel the situation with an already infected woman. However, one European study has reported significantly higher infection rates in breast fed babies 88.
It seems probable that breast feeding carries a risk of infecting an otherwise non-infected baby. This extra risk is probably small, and current belief is that breast feeding is not a major route of transmission. The avoidance of breast feeding itself carries risks, particularly in developing countries but also to a lesser extent in the industrialized world. Advice about breast feeding is therefore dependent on an assessment of these different risks in the population. Mathematical models of the event frequencies Johnstone. HIV and pregnancy 83 which have to be taken into account have been suggested 133, In general terms, HIV infected women in developed countries should be advised to bottle feed. In countries where formula milk is not readily available, and where poor standards of hygiene are used in constituting milk powder, breast feeding should continue to be promoted, as offering infants the optimum chances for survival.
Conclusions
Progress is being made in several aspects of the interaction between HIV and pregnancy. However, many uncertainties remain. In particular, the timing and mechanisms of vertical transmission are critically important but poorly understood, and there is so far no effective way of interrupting transmission to the baby. There is no reliable way of predicting early in pregnancy which woman will transmit infection, and no fully established method of early diagnosis of infection status in the infant. The only certainty about HIV and pregnancy is that the problem will not disappear in the near future. 
